UB Paderborn / Katalog / Suche / in CDI

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients

Cancers, 2024-04, Vol.16 (8), p.1487

2024

Volltextzugriff (PDF)

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

Clinical cardiology (Mahwah, N.J.), 2022-09, Vol.45 (9), p.913-920

2022

Volltextzugriff (PDF)

Safety and feasibility of balloon aortic valvuloplasty in non‐TAVI centers: The “BAV for life” experience

Catheterization and cardiovascular interventions, 2019-01, Vol.93 (1), p.E63-E70

2019

Volltextzugriff (PDF)

The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome

Journal of clinical medicine, 2020-12, Vol.9 (12), p.3926

2020

Volltextzugriff (PDF)

Lights and shadows of long-term dual antiplatelet therapy in “real life” clinical scenarios

Journal of thrombosis and thrombolysis, 2018-11, Vol.46 (4), p.559-569

2018

Volltextzugriff (PDF)

Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy

European heart journal, 2006-06, Vol.27 (11), p.1311-1318

2006

Volltextzugriff (PDF)

Cardiac Rehabilitation in the Health Plans of Campania

Monaldi archives for chest disease, 2016-02, Vol.68 (2)

2016

Volltextzugriff (PDF)

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

European heart journal, 2020-06, Vol.41 (22), p.2083-2088

2020

Volltextzugriff (PDF)

BERBERINE ASSOCIATED TO DAPAGLIFLOZIN EXERTS SIGNIFICANT CARDIOPROTECTIVE EFFECTS IN CARDIAC CELLS EXPOSED TO THE HER2-BLOKING AGENT TRASTUZUMAB THROUGH PAMPK ACTIVATION AND REDUCTION IN INTERLEUKIN-6 LEVELS

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.2271-2271

2023

Volltextzugriff (PDF)

Transcranial Doppler Ultrasound: Incremental Diagnostic Role in Cryptogenic Stroke Part II

Journal of cardiovascular echography, 2016-07, Vol.26 (3), p.71-77

2016

Volltextzugriff (PDF)

Cardiovascular Risk Profile and Lifestyle Habits in a Cohort of Italian Cardiologists. Results of the SOCRATES Survey

Monaldi archives for chest disease, 2015-11, Vol.80 (3)

2015

Volltextzugriff (PDF)

Abstract 12406: Sglt2i Dapagliflozin Associated to Berberine Reduces Cardiac Cell Apoptosis and Necrosis During Exposure to Her-2 Blocking Agents Through Induction of Pampk and Reduction of Inflammasome, Il-6, Methylglyoxal and Leukotrienes-B4 Levels

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Abstract 12402: Sacubitril-Valsartan Increases Pampk and Reduces Inflammasome, Myddosome, Il-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Longitudinal Strain and Ejection Fraction

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Abstract 10603: Dapagliflozin Increases Ampk, Reduces Fibrosis/Hypertrophy and Nlrp-3, Il-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Cardiac Function

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Circulation (New York, N.Y.), 2022-10, Vol.146 (16), p.1196-1206

2022

Volltextzugriff (PDF)

Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak

Circulation (New York, N.Y.), 2020-06, Vol.141 (24), p.2035-2037

2020

Volltextzugriff (PDF)

Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients

International journal of cardiology, 2007-10, Vol.121 (3), p.298-301

2007

Volltextzugriff (PDF)

DAPAGLIFLOZIN ASSOCIATED TO SACUBITRIL/VALSARTAN (LCZ696) EXERTS ADDITIVE CARDIOPROTECTION IN HUMAN CARDIOMYOCYTES EXPOSED SEQUENTIALLY TO DOXORUBICIN AND TRASTUZUMAB THROUGH MYD88, NLRP3 MEDIATED PATHWAYS AND PRO-INFLAMMATORY CYTOKINES

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.1886

2022

Volltextzugriff (PDF)

Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study

Europace (London, England), 2019-02, Vol.21 (2), p.230-238

2019

Volltextzugriff (PDF)

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study

International journal of cardiology, 2013-09, Vol.167 (6), p.2895-2903

2013

Volltextzugriff (PDF)

ANMCO Position paper - 2023 ANMCO States General: The shortage of healthcare personnel in the cardiology field

Giornale italiano di cardiologia (2006), 2024-02, Vol.25 (2), p.115

2024

Volltextzugriff (PDF)

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease

European heart journal supplements, 2018-05, Vol.20 (suppl_F), p.F1-F74

2018

Volltextzugriff (PDF)

Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds—the TEMISTOCLE study

The American heart journal, 2003-10, Vol.146 (4), p.735-735

2003

Volltextzugriff (PDF)

ANMCO POSITION PAPER: The role of cardiology in the management of the health needs in the post-Covid-19 era

European heart journal supplements, 2020-08, Vol.22 (Suppl G), p.G217-G222

2020

Volltextzugriff (PDF)

COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry

European heart journal. Quality of care & clinical outcomes, 2021-09, Vol.7 (5), p.513-520

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

Safety and feasibility of balloon aortic valvuloplasty in non‐TAVI centers: The “BAV for life” experience

The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome

Lights and shadows of long-term dual antiplatelet therapy in “real life” clinical scenarios

Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy

Cardiac Rehabilitation in the Health Plans of Campania

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

BERBERINE ASSOCIATED TO DAPAGLIFLOZIN EXERTS SIGNIFICANT CARDIOPROTECTIVE EFFECTS IN CARDIAC CELLS EXPOSED TO THE HER2-BLOKING AGENT TRASTUZUMAB THROUGH PAMPK ACTIVATION AND REDUCTION IN INTERLEUKIN-6 LEVELS

Transcranial Doppler Ultrasound: Incremental Diagnostic Role in Cryptogenic Stroke Part II

Cardiovascular Risk Profile and Lifestyle Habits in a Cohort of Italian Cardiologists. Results of the SOCRATES Survey

Abstract 12406: Sglt2i Dapagliflozin Associated to Berberine Reduces Cardiac Cell Apoptosis and Necrosis During Exposure to Her-2 Blocking Agents Through Induction of Pampk and Reduction of Inflammasome, Il-6, Methylglyoxal and Leukotrienes-B4 Levels

Abstract 12402: Sacubitril-Valsartan Increases Pampk and Reduces Inflammasome, Myddosome, Il-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Longitudinal Strain and Ejection Fraction

Abstract 10603: Dapagliflozin Increases Ampk, Reduces Fibrosis/Hypertrophy and Nlrp-3, Il-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Cardiac Function

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak

Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients

DAPAGLIFLOZIN ASSOCIATED TO SACUBITRIL/VALSARTAN (LCZ696) EXERTS ADDITIVE CARDIOPROTECTION IN HUMAN CARDIOMYOCYTES EXPOSED SEQUENTIALLY TO DOXORUBICIN AND TRASTUZUMAB THROUGH MYD88, NLRP3 MEDIATED PATHWAYS AND PRO-INFLAMMATORY CYTOKINES

Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study

ANMCO Position paper - 2023 ANMCO States General: The shortage of healthcare personnel in the cardiology field

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease

Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds—the TEMISTOCLE study

ANMCO POSITION PAPER: The role of cardiology in the management of the health needs in the post-Covid-19 era

COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry

Suchergebnisse filtern